Drug Trial Radar · NCT04786990
Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD
Last checked: Nov 20, 2026Latest source record: May 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Jul 27, 2021
Primary completion
May 23, 2023
Study completion Jul 26, 2023
Sponsor
- Lead sponsor
- Supernus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open label, flexible-dose study evaluating the safety and efficacy of SPN-812 administered with psychostimulants in children and adolescents (6 to 17 years of age) with Attention-Deficit/Hyperactivity Disorder (ADHD).
Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions
SPN-812Drug
Viloxazine extended-release capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse Events During 8 Weeks of Adjunct SPN-812 TreatmentTime frame: Weeks 1-8
Locations
17 sites in 2 countries. Site status is shown where the registry gives one.
Preferred Research Partners, Inc.
Little Rock, Arkansas
NRC Research Institute
Orange, California
Miami Clinical Research
Miami, Florida
APG Research, LLC
Orlando, Florida
Elite Clinical Trials
Blackfoot, Idaho
Elite Clinical Trials
Rexburg, Idaho
Qualmedica Research, LLC
Evansville, Indiana
Psychiatric Associates Purehealth Medical Center
Overland Park, Kansas
Midwest Research Group
Saint Charles, Missouri
Alivation Research, LLC
Lincoln, Nebraska
Center for Psychiatry and Behavioral Medicine
Las Vegas, Nevada
SP Research, PLLC
Oklahoma City, Oklahoma
Coastal Carolina Research Center
North Charleston, South Carolina
Gadolin Research, LLC
Beaumont, Texas
Family Psychiatry of The Woodlands
The Woodlands, Texas
Northwest Clinical Research Center
Bellevue, Washington
Barbara Diaz Hernandez MD Research, INC.
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.